Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
557 Determining the efficacy of ADCC by the 3D-EX ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.
